BBIO vs D · rev $221.9M vs P/E 21, rev $16.51B
BridgeBio Pharma Inc (BBIO) versus Dominion Energy Inc (D) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Dominion Energy Inc (D) is a utilities - regulated electric company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported D revenue for 2025-12-31 was $16.51B. Net income was $3.00B. Revenue was up 385.5% from 2024-12-31 to 2025-12-31. D currently screens at market cap $47.07B and trailing P/E 21.3.
BBIO currently screens at market cap $13.24B. D currently screens at market cap $47.07B and trailing P/E 21.3.
Not investment advice. Open the BBIO and D stock pages for the full models.
Not investment advice.